Paclitaxel salvage therapy `feasible' in pancreatic cancer

By  

Inpharma, Vol. 1, Iss. 1261, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Paclitaxel: As Adjuvant or Neoadjuvant Therapy in Early Breast Cancer

By Dene Simpson   Greg L. Plosker  

Drugs, Vol. 64, Iss. 16, 2004-01 ,pp. : 1839-1847

Adis International

Access to resources Recommend Favorite

Combination therapy of zibotentan with cisplatinum and paclitaxel is an effective regimen for epithelial ovarian cancer

By Rosanò Laura   Cianfrocca Roberta   Spinella Francesca   Di Castro Valeriana   Natali Pier G.   Bagnato Anna  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 6, 2010-06 ,pp. : 676-681

NRC Research Press

Access to resources Recommend Favorite

Paclitaxel poliglumex for ovarian cancer

By Galic Vijaya L   Wright Jason D   Lewin Sharyn N   Herzog Thomas J  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 6, 2011-06 ,pp. : 813-821

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial

By Ta-Chung Chao   Zyting Chu   Ling-Ming Tseng   Tzeon-Jye Chiou   Ruey-Kuen Hsieh   Wei-Shu Wang   Chueh-Chuan Yen   Muh-Hwa Yang   Liang-Tsai Hsiao   Jin-Hwang Liu   Po-Min Chen  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 171-177

Springer Publishing Company

Access to resources Recommend Favorite